Embed Notice

HTML Code

<blockquote style="position: relative; padding-left: 55px;"><section><a href="https://mastodon.social/users/mattotcha/statuses/113379212698130198">Matt Willemsen (mattotcha@mastodon.social)'s status on Sunday, 27-Oct-2024 20:49:47 JST</a><a href="https://mastodon.social/@mattotcha" title="mattotcha@mastodon.social"><img src="https://gnusocial.jp/avatar/220996-48-20231207114928.webp" width="48" height="48" alt="Matt Willemsen" style="position: absolute; left: 0; top: 0;">Matt Willemsen</a></section><article><p>Alzheimer’s Breakthrough: Popular Diabetes Drug Ozempic Linked to Much Lower Risk<br>Semaglutide may reduce Alzheimer’s risk in type 2 diabetes patients, with research suggesting significant protective benefits compared to other diabetes drugs.<br><a href="https://scitechdaily.com/alzheimers-breakthrough-popular-d" rel="nofollow noreferrer">https://scitechdaily.com/alzheimers-breakthrough-popular-d</a></p></article><footer><a rel="bookmark" href="https://gnusocial.jp/conversation/3889176#notice-7601992">In conversation</a><time datetime="2024-10-27T20:49:47+09:00" title="Sunday, 27-Oct-2024 20:49:47 JST">about a month ago</time> <span>from <span><a href="https://mastodon.social/@mattotcha/113379212698130198" rel="external" title="Sent from mastodon.social via ActivityPub">mastodon.social</a></span></span><a href="https://mastodon.social/@mattotcha/113379212698130198">permalink</a><h4>Attachments</h4><ol><li><article><header><div>Domain not in remote thumbnail source whitelist: scitechdaily.com</div><h5><a href="https://scitechdaily.com/alzheimers-breakthrough-popular-diabetes-drug-ozempic-linked-to-much-lower-risk/">Alzheimer’s Breakthrough: Popular Diabetes Drug Ozempic Linked to Much Lower Risk</a></h5><div> from <span>Mike O'Neill</span></div></header><div>Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits compared to other diabetes drugs. Researchers at Case Western Reserve School of Medicine have found that semaglutide, a popular drug used for both diabetes and weight loss</div><footer></footer></article></li></ol></footer></blockquote>

Corresponding Notice

Embed this notice
Matt Willemsen (mattotcha@mastodon.social)'s status on Sunday, 27-Oct-2024 20:49:47 JST Matt Willemsen
Alzheimer’s Breakthrough: Popular Diabetes Drug Ozempic Linked to Much Lower Risk
Semaglutide may reduce Alzheimer’s risk in type 2 diabetes patients, with research suggesting significant protective benefits compared to other diabetes drugs.
https://scitechdaily.com/alzheimers-breakthrough-popular-d
In conversationabout a month ago from mastodon.socialpermalink
Attachments
1. Domain not in remote thumbnail source whitelist: scitechdaily.com
  Alzheimer’s Breakthrough: Popular Diabetes Drug Ozempic Linked to Much Lower Risk
  from Mike O'Neill
  Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits compared to other diabetes drugs. Researchers at Case Western Reserve School of Medicine have found that semaglutide, a popular drug used for both diabetes and weight loss

Public

Embed Notice

HTML Code

Corresponding Notice